Contents
|
Tx | Unstaged primary tumor |
---|---|
T0 | There is no evidence of primary tumor |
Tis | Carcinoma in situ |
Ta | Non-invasive verrucous carcinoma |
T1 | The tumor invades the subepithelial connective tissue. |
T2 | The tumor invades the corpus spongiosum or cavernosum. |
T3 | The tumor invades the urethra or the prostate gland. |
T4 | The tumor invades other adjacent tissues. |
Ν (locoregional lymph-nodes)
Nx | Lymph nodes can not be assessed. |
---|---|
N0 | There is no metastases to the lymph-nodes. |
N1 | Invasion of a single superficial inguinal lymph node |
N2 | Invasion of multiple or bilateral superficial inguinal lymph nodes |
N3 | Invasion of the deep inguinal and/or pelvic lymph-nodes |
Μ (metastases)
Mx | Distal metastases that can not be assessed. |
---|---|
M0 | Absence of metastases |
M1 | Presence of distal metastases |
Name |
|
---|---|
Special features |
Assessment based on the clinical or pathological stage (two nomograms) |
What does it calculate? |
Assessment of the 5-year survival from penile cancer |
Creator |
Kattan MW, The Cleveland Clinic Foundation |
First publication |
Kattan MW, et al.. J Urol. 2006; 175: 2103-8 |
References |
35 |
Agent / name |
Cleveland Clinic |
Link |
|
ISUD Evaluation |
** |
Name |
|
---|---|
Special features |
Assessment based on the clinical stage for primary squamous carcinomas that were subjected to resection (partial or total penectomy) |
What does it calculate? |
Probability of lymph node infiltration in penile cancer |
Creator |
Ficarra V, University of Verona |
First publication |
Ficarra V, et al. J Urol. 2006; 175: 1700-4 |
References |
56 |
Institution / name |
|
Link |
|
ISUD Evaluation |
** |
Name |
|
---|---|
Special features |
For primary squamous carcinomas submitted to resection (simple excision, partial penectomy, total penectomy) |
What does it calculate? |
Assessment of penile cancer-specific mortality for the next 1-5 years after surgical excision |
Creator |
Zini L, University of Montreal |
First publication |
Zini L, et al. Clin Cancer Res. 2009; 15: 1013-8 |
References |
8 |
Institution / name |
Cancer Prognostics and Health Outcomes Unit, University of Montreal |
Link |
|
ISUD Evaluation |
** |